Hit enter to search or ESC to close
NuView Life SciencesNuView Life SciencesNuView Life SciencesNuView Life Sciences
  • Home
  • About Us
    • Mission
    • Leadership
      • Management Team
      • Directors
      • Clinical Collaborators
      • Consultants
  • Products
    • In Vivo Diagnostics
    • In Vitro Diagnostics
    • Theranostics Applications
    • Why Research for New Diagnostics?
  • Pipeline
  • News
    • NuView Life Sciences in the News
    • Press Releases
  • Publications
  • Contact Us
NuView Life Sciences
Monthly Archives

January 2019

Jan 28
Love0

Investigation into a novel, but simple, non-invasive approach for detection of genitourinary cancer.

By Karla Jo Helms Publications

Cancer remains one of the most formidable diseases of mankind. Genitourinary cancers, such as those involving prostate (CaP) and bladder urothelium, are common malignancies. However,…

Read More
Jan 28
Love0

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Peptide Receptor 1 (VPAC1) Targeted Detection of Genitourinary Cancer: A Urinary Assay

By Karla Jo Helms Publications

Prostate cancer (CaP) and bladder urothelial cancer (BUC) are the two most common malignancies in urology, and both overexpress VPAC1. VPAC1 is overexpressed at the…

Read More

Categories

  • News
  • NuView Life Sciences in the News
  • Press Releases
  • Publications

Recent Posts

  • NuView Life Sciences Provides Corporate Update on NV-VPAC1 Theranostic for Breast Cancer
  • Targeting VPAC1 Receptors for Imaging Glioblastoma
  • NuView Life Sciences Creates Subsidiary for Latin American Market
  • Jay Bishoff, MD, joins The Smith Institute for Urology
  • Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics

Archives

  • October 2022
  • January 2022
  • November 2021
  • August 2021
  • February 2021
  • January 2021
  • November 2020
  • August 2020
  • June 2020
  • May 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • April 2019
  • March 2019
  • January 2019
  • November 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • March 2013
  • February 2013
  • February 2000
  • January 2000

NuView Life Sciences is a clinical stage oncology company addressing unmet medical needs.

Read More

Contact Address

NuView Life Sciences, Inc
1389 Center Drive, Suite 200
Park City, Utah 84098

Office: 435.647.9758 

Contact us:
admin@nuviewlifesciences.com

Media inquiries:
Jennifer K. Zimmons
jzimmons@zimmonsic.com

The most recent press

  • NuView Life Sciences Provides Corporate Update on NV-VPAC1 Theranostic for Breast Cancer October 5, 2022
  • NuView Life Sciences Creates Subsidiary for Latin American Market November 17, 2021

Quick Links

  • Home
  • About Us
  • Products
  • Pipeline
  • News
  • Publications

© 2023 NuView Life Sciences. Terms of Use

  • Home
  • About Us
    • Mission
    • Leadership
      • Management Team
      • Directors
      • Clinical Collaborators
      • Consultants
  • Products
    • In Vivo Diagnostics
    • In Vitro Diagnostics
    • Theranostics Applications
    • Why Research for New Diagnostics?
  • Pipeline
  • News
    • NuView Life Sciences in the News
    • Press Releases
  • Publications
  • Contact Us